4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-15-056198
CIK 0001270073operating
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 9:00 PM ET
Size
8.4 KB
Accession
0001144204-15-056198
Insider Transaction Report
Form 4
WILLIAMS NICOLE
Director
Transactions
- Sale
Common Stock
2015-09-21$194.82/sh−973$189,560→ 962 total - Exercise/Conversion
Common Stock
2015-09-21$9.82/sh+973$9,557→ 1,935 total - Exercise/Conversion
Options to Purchase Common Stock
2015-09-21−973→ 2,921 totalExercise: $9.82Exp: 2019-09-16→ Common Stock (973 underlying)
Footnotes (2)
- [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on November 21, 2014.
- [F2]All shares underlying this option have vested.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 9:00 PM ET
- Size
- 8.4 KB